The chronic disease patient is a critical stakeholder in emerging markets because they often have to pay for their healthcare out of pocket. Moreover, these markets often don’t have formal primary care systems, so the patient is the only constant in the journey. Understanding their journey is critical in order to fully exploit these potential new markets. Now more than ever, it is critical that pharma companies have a thorough understanding of the patient journey and how this is impacted by healthcare developments in each country.
Watch this webcast in which our experts explore the chronic disease patient journey in emerging markets. Utilising knowledge and experience garnered from conducting more than 70 projects annually across a wide variety of emerging markets, we will examine the patient journey and provide you with the insights you require to identify the key inflection points in these rapidly changing and diverse regions.
What are the key takeaways?
- Learn why patient journey understanding is critical to market success in growth markets
- Understand the universal truths of the chronic disease patient
- Identify common challenges faced by the chronic disease patient at each stage of the patient journey in emerging markets
- Explore how and why the patient journey differs between emerging markets